Tenax Therapeutics Inc
TENX
Market Cap$23.92M
Close$
$0.62
89.3% downside
Current Fair Value
89.3% downsideOvervalued by 89.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $23.92 Million |
|---|---|
| Enterprise Value | $-70,934,955.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.12 |
| Beta | 1.87 |
| Outstanding Shares | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.66 |
|---|---|
| PEG | 0.88 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -12251.29 |
| Enterprise Value to EBIT | 22.06 |
| Enterprise Value to Net Income | -75 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tenax Therapeutics Inc
CEO: John Kelley